In glioblastoma (GBM), CLOCK or BMAL1 can promote tumor growth by regulating glioma cell proliferation and migration through the NFκB pathway and supporting glioma stem-cell function by managing anabolic metabolism [33,37]. Here, NFKB1 is linked to central nervous system cancer.